financetom
Business
financetom
/
Business
/
China Yuchai Unit Starts Shipment of Casting Products to Germany
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China Yuchai Unit Starts Shipment of Casting Products to Germany
Aug 13, 2025 4:37 AM

07:06 AM EDT, 08/13/2025 (MT Newswires) -- China Yuchai International ( CYD ) said Wednesday its subsidiary Guangxi Yuchai Foundry has started shipping its first batch of high-end cylinder head castings to a customer in Germany.q

The company said it will manufacture 30,000 cylinder head castings for the order.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vail Resorts' Epic Pass Turnaround Could Take Time, Says BofA Securities
Vail Resorts' Epic Pass Turnaround Could Take Time, Says BofA Securities
Sep 30, 2025
11:06 AM EDT, 09/30/2025 (MT Newswires) -- Vail Resorts' ( MTN ) initiatives to drive its Epic pass sales could take time to translate to results given the short operating season and the company's pass selling trends, BofA Securities said in a Tuesday note. The company reported a fiscal Q4 net loss of $5.08 per diluted share, widening from $4.70...
Lululemon Faces More Profit Pressure After Steep Guidance Drop, Morgan Stanley Says
Lululemon Faces More Profit Pressure After Steep Guidance Drop, Morgan Stanley Says
Sep 30, 2025
11:05 AM EDT, 09/30/2025 (MT Newswires) -- Lululemon athletica's (LULU) sharper-than-expected earnings guidance cut may signal further downside over the next year, Morgan Stanley said Monday in a note. Earlier this month, lululemon projected diluted full-year fiscal earnings per share of $12.77 to $12.97, down from $14.58 to $14.78, a bigger decline than forecast, Morgan Stanley said. Morgan Stanley trimmed...
IO Biotech Faces Setback as FDA Opposes Cylembio BLA Submission, Morgan Stanley Says
IO Biotech Faces Setback as FDA Opposes Cylembio BLA Submission, Morgan Stanley Says
Sep 30, 2025
11:06 AM EDT, 09/30/2025 (MT Newswires) -- IO Biotech ( IOBT ) faces increased near-term uncertainty after reporting that the US Food and Drug Administration recommended it not submit a biologics license application for cylembio in melanoma after a phase 3 trial fell narrowly short of statistical significance, Morgan Stanley said in a Tuesday report. The biopharmaceutical company said Monday...
AnaptysBio's Split Announcement Seems 'Awkward' Amid Clinical Activities, Truist Securities Says
AnaptysBio's Split Announcement Seems 'Awkward' Amid Clinical Activities, Truist Securities Says
Sep 30, 2025
11:07 AM EDT, 09/30/2025 (MT Newswires) -- AnaptysBio's ( ANAB ) recent announcement of its decision to explore a split into two companies seems a bit awkward, if not premature amid moving parts on the clinical front, Truist Securities said in a note to clients late Monday. The investment firm highlighted the fact that key updates are expected in Q4...
Copyright 2023-2026 - www.financetom.com All Rights Reserved